Celltrion Group completes first step in developing antiviral treatment to fight COVID-19

Celltrion Group completes first step in developing antiviral treatment to fight COVID-19

Celltrion Group today announced key milestones in its efforts to fight the 2019 novel coronavirus (COVID-19) pandemic. As part of its emergency preparedness plan...
Image of clipboards with medical papers,a stethoscope and pencil to show NICE guidelines on active management of patients with COVID-19

NICE guidelines on active management of patients with COVID-19

The National Institute for Health and Care Excellence (NICE) has published its first three rapid guidelines on the active management of patients with COVID-19...
eyeforpharma Barcelona goes VIRTUAL

eyeforpharma Barcelona goes VIRTUAL

Spotlight: Advertorial from Pf Partners Hi Covid-19 has undoubtedly created one of the most challenging environments of the modern era. Together, we must step up to...
Image of SHerlock Holmes type character with a large magnifying glass to show CMA launches COVID-19 taskforce to monitor market practices

CMA launches COVID-19 taskforce to monitor market practices

The CMA is launching a COVID-19 taskforce to tackle negative impacts within its remit of the coronavirus pandemic. The outbreak of Covid-19 is an unprecedented...
Image of seesaw with a lightbulb on the left and money on the right to show LifeArc launches £10m COVID-19 clinical research fund

LifeArc launches £10m COVID-19 clinical research fund

LifeArc, a UK-based medical research charity, has created a £10m COVID-19 clinical research fund to support research to accelerate the development and testing of...
Image of lab equipment to show Synairgen to start trial of SNG001 in COVID-19

Synairgen to start trial of SNG001 in COVID-19

Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...
Image of a microscope and papers to show Study of siltuximab for treating COVID-19 serious respiratory complications initiated

Study of siltuximab for treating COVID-19 serious respiratory complications initiated

A study of siltuximab for treating COVID-19 serious respiratory complications has been initiated. EUSA Pharma has announced the initiation of the Papa Giovanni XXIII Hospital...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

First coronavirus vaccine clinical trial starts

The first coronavirus vaccine clinical trial has started at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The Phase 1 clinical trial is...
Image of a hand with germs on it to show Roche COVID-19 test gets emergency FDA authorisation

FDA emergency authorisation for Roche’s COVID-19 test

Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
Image of scientists standing around a giant magnifying glass with books, charts and research to show Elsevier gives full access to its coronavirus information centre content

Elsevier gives full access to its coronavirus information centre content

Elsevier is giving full access to its content on its coronavirus information centre for PubMed Central and other public health databases, such as the...

Latest articles

Image of a head with icons coming out of the brain with a light bulb, globe, cog, clock, microscope and more to show APM study reveals the contribution of project management in pharma and life science

APM study reveals the contribution of project management in pharma and life science

A study by the Association for Project Management has revealed the contribution of projects and project management in pharma and life sciences. Rebecca Fox, Head...
Image of a participant being injected with Medicago COVID-19 vaccine candidate

Medicago begins Phase I clinical trials for its COVID-19 vaccine candidate

Medicago, a biopharmaceutical company headquartered in Quebec City, has started Phase I clinical trials for its plant-derived COVID-19 vaccine candidate, administering the first doses...
Image of light bulbs as a newton's cradle with the final bulb illuminated to sow Becoming a leading pharma company in the new normal

Becoming a leading pharma company in the new normal

The pharma supply chain has been stress tested to breaking point in the past few months. Many life science companies have transitioned to entirely...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of two people at a table joining though bubbles to show COVID-19: A Catalyst for Change in Government-Industry Partnership

COVID-19: A Catalyst for Change in Government-Industry Partnership

How outsourced pharma healthcare workers are supporting the Office for National Statistics COVID-19 Infection Survey as part of a Government-industry partnership. COVID-19 has seen the...
Image of light bulbs as a newton's cradle with the final bulb illuminated to sow Becoming a leading pharma company in the new normal

Becoming a leading pharma company in the new normal

The pharma supply chain has been stress tested to breaking point in the past few months. Many life science companies have transitioned to entirely...
Image of an iPad s a swimming pool with ladder and life ring to show Innovative technology in the medical devices market

Innovative technology in the medical devices market

Bernard Ross explores innovative technology in the medical devices market especially relating to venous thromboembolism (VTE). According to Cordant Recruitment, the global medical devices market...

Market Access in practice: do you have a strategy?

This article is a little old... but if you're interested in Market Access we have plenty of new content: July 2018 Market Access Special Edition...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription